Click for best price
Postpemic Era Cancer Testing/Screening Market Size, Share 2022
Summary
The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery.
2022 is a year of continuous recovery. Global supply chain disturbance, geopolitical tension, energy price fluctuation, local labor shortage and rising raw material prices will affect the resilience of economic recovery. The International Monetary Fund (IMF) predicts that the world economy will grow by 4.4% in 2022, of which the U.S. economy will grow by about 4%. Driven by China and India, Asia is expected to become the fastest growing region in the world in 2022. However, China's economic growth has slowed down. The 2022 government work report shows that the expected target of economic growth is set at about 5.5%.
According to research, China has set a growth rate of about 5.5%, which not only focuses on the speed of economic growth, but also anchors the quality of economic development. Scientific and technological innovation, economic and social digitization and green development will be the long-term goals of China's economic development. It is expected that in 2022, major economies such as the United States, Europe and China will introduce more favorable policies to drive the development of switching power supply industry.
(Post-pandemic Era)-Global Cancer Testing/Screening Market Segment Research Report 2022?, which aims to sort out the development status and trends of the Cancer Testing/Screening industry at home and abroad, estimate the overall market scale of the Cancer Testing/Screening industry and the market share of major countries, Cancer Testing/Screening industry, and study and judge the downstream market demand of Cancer Testing/Screening through systematic research, Analyze the competition pattern of Cancer Testing/Screening, so as to help solve the pain points of various stakeholders in Cancer Testing/Screening industry. This industry research report combines desktop research, qualitative interviews with insiders or experts and other methods to strive for the objectivity and integrity of conclusions and data.
Regional Segmentation (Value; Revenue, USD Million, 2018-2028) of Cancer Testing/Screening Market by Research Include
USA
Europe
China
Japan
India
Korea
Southeast Asia
Competitive Analysis; Who are the Major Players in Cancer Testing/Screening Market?
Dias Orin
Epigenetics
Techlab
Positive Bioscience
Genextropy
M Genomics
20/20 GeneSystems
AB SCIEX
Abbott Laboratories
Major Type of Cancer Testing/Screening Covered in Research report:
Magnetic Resonance Imaging (MRI)
Human Papillomavirus (HPV) Testing
Colonoscopy
Others
Application Segments Covered in Research Market
Lung Cancer
Blood Cancer
Bone Cancer
Gall Bladder Cancer
Others
For any other requirements, please feel free to contact us and we will provide you customized report.
| Report Attributes |
Report Details |
| Report Title |
(Post-pandemic Era)-Global Cancer Testing/Screening Market Segment Research Report 2022 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
81 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
Table of Contents
Global Cancer Testing/Screening Market Segment Research Report 2022
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global Cancer Testing/Screening Market by Value
2.2.1 Global Cancer Testing/Screening Revenue by Type
2.2.2 Global Cancer Testing/Screening Market by Value
2.3 Global Cancer Testing/Screening Market by Sales
2.3.1 Global Cancer Testing/Screening Sales by Type
2.3.2 Global Cancer Testing/Screening Market by Sales
3. The Major Driver of Cancer Testing/Screening Industry
3.1 Historical & Forecast Global Cancer Testing/Screening Sales and Revenue (2018-2028)
3.2 Largest Application for Cancer Testing/Screening (2018-2028)
3.3 The Major Downstream Company in China Market 2022
4. Global and Regional Cancer Testing/Screening Market
4.1 Regional Market Size in Terms of Sales (2022 & 2028)
4.2 Regional Market Share in Terms of Revenue (2022 & 2028)
4.3 Concentration Ratio (CR5& CR10) of Cancer Testing/Screening Market
4.4 Mergers & Acquisitions, Expansion Plans
5. US Cancer Testing/Screening Sales (2018-2028)
5.1 Current and Estimated Sales Breakdown by Type (2018-2028)
5.2 Current and Estimated Sales Breakdown by Application (2018-2028)
5.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
5.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
6. Europe Cancer Testing/Screening Sales (2018-2028)
6.1 Current and Estimated Sales Breakdown by Type (2018-2028)
6.2 Current and Estimated Sales Breakdown by Application (2018-2028)
6.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
6.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
7. China Cancer Testing/Screening Sales (2018-2028)
7.1 Current and Estimated Sales Breakdown by Type (2018-2028)
7.2 Current and Estimated Sales Breakdown by Application (2018-2028)
7.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
7.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
8. Japan Cancer Testing/Screening Sales (2018-2028)
8.1 Current and Estimated Sales Breakdown by Type (2018-2028)
8.2 Current and Estimated Sales Breakdown by Application (2018-2028)
8.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
8.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
9. India Cancer Testing/Screening Sales (2018-2028)
9.1 Current and Estimated Sales Breakdown by Type (2018-2028)
9.2 Current and Estimated Sales Breakdown by Application (2018-2028)
9.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
9.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
10. Korea Cancer Testing/Screening Sales (2018-2028)
10.1 Current and Estimated Sales Breakdown by Type (2018-2028)
10.2 Current and Estimated Sales Breakdown by Application (2018-2028)
10.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
10.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
11. Southeast Asia Cancer Testing/Screening Sales (2018-2028)
11.1 Current and Estimated Sales Breakdown by Type (2018-2028)
11.2 Current and Estimated Sales Breakdown by Application (2018-2028)
11.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
11.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
12. South America Cancer Testing/Screening Sales (2018-2028)
12.1 Current and Estimated Sales Breakdown by Type (2018-2028)
12.2 Current and Estimated Sales Breakdown by Application (2018-2028)
12.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
12.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
13. Global Cancer Testing/Screening Average Price Trend
13.1 Market Price for Each Type of Cancer Testing/Screening in US (2018-2022)
13.2 Market Price for Each Type of Cancer Testing/Screening in Europe (2018-2022)
13.3 Market Price for Each Type of Cancer Testing/Screening in China (2018-2022)
13.4 Market Price for Each Type of Cancer Testing/Screening in Japan (2018-2022)
13.5 Market Price for Each Type of Cancer Testing/Screening in India (2018-2022)
13.6 Market Price for Each Type of Cancer Testing/Screening in Korea (2018-2022)
13.7 Market Price for Each Type of Cancer Testing/Screening in Southeast Asia (2018-2022)
13.8 Market Price for Each Type of Cancer Testing/Screening in South America (2018-2022)
14. Industrial Chain (Impact of COVID-19)
14.1 Cancer Testing/Screening Industrial Chain Analysis
14.2 Downstream
14.3 Impact of COVID-19
14.4 Post-pandemic Era
14.5 Technology Trends of Cancer Testing/Screening
15. Cancer Testing/Screening Competitive Landscape
15.1 Dias Orin
15.1.1 Dias Orin Company Profiles
15.1.2 Dias Orin Product Introduction
15.1.3 Dias Orin Cancer Testing/Screening Sales, Revenue (2018-2022)
15.1.4 Strategic initiatives
15.2 Epigenetics
15.2.1 Epigenetics Company Profiles
15.2.2 Epigenetics Product Introduction
15.2.3 Epigenetics Cancer Testing/Screening Sales, Revenue (2018-2022)
15.2.4 Strategic initiatives
15.3 Techlab
15.3.1 Techlab Company Profiles
15.3.2 Techlab Product Introduction
15.3.3 Techlab Cancer Testing/Screening Sales, Revenue (2018-2022)
15.3.4 Strategic initiatives
15.4 Positive Bioscience
15.4.1 Positive Bioscience Company Profiles
15.4.2 Positive Bioscience Product Introduction
15.4.3 Positive Bioscience Cancer Testing/Screening Sales, Revenue (2018-2022)
15.4.4 Strategic initiatives
15.5 Genextropy
15.5.1 Genextropy Company Profiles
15.5.2 Genextropy Product Introduction
15.5.3 Genextropy Cancer Testing/Screening Sales, Revenue (2018-2022)
15.5.4 Strategic initiatives
15.6 M Genomics
15.6.1 M Genomics Company Profiles
15.6.2 M Genomics Product Introduction
15.6.3 M Genomics Cancer Testing/Screening Sales, Revenue (2018-2022)
15.6.4 Strategic initiatives
15.7 20/20 GeneSystems
15.7.1 20/20 GeneSystems Company Profiles
15.7.2 20/20 GeneSystems Product Introduction
15.7.3 20/20 GeneSystems Cancer Testing/Screening Sales, Revenue (2018-2022)
15.7.4 Strategic initiatives
15.8 AB SCIEX
15.8.1 AB SCIEX Company Profiles
15.8.2 AB SCIEX Product Introduction
15.8.3 AB SCIEX Cancer Testing/Screening Sales, Revenue (2018-2022)
15.8.4 Strategic initiatives
15.9 Abbott Laboratories
15.9.1 Abbott Laboratories Company Profiles
15.9.2 Abbott Laboratories Product Introduction
15.9.3 Abbott Laboratories Cancer Testing/Screening Sales, Revenue (2018-2022)
15.9.4 Strategic initiatives
16. Conclusion
17. Methodology and Data Source
LIST OF TABLES & FIGURES
List of Tables and Figures
Figure 1. Total Sales by Application of Cancer Testing/Screening Industry (Volume)
Figure 2. Cancer Testing/Screening Sales by Regions in 2022
Figure 3. Regional Market Share in Terms of Revenue (2022&2028)
Figure 4. The Top 10 and 5 Players Market Share by Cancer Testing/Screening Revenue in 2022
Figure 5. US Cancer Testing/Screening Sales (2018-2028)
Figure 6. Sales Breakdown by Type (%)
Figure 7. Sales Breakdown by Type (%)
Figure 8. Sales Breakdown by Application (%)
Figure 9. Revenue Breakdown by Type (%)
Figure 10. Revenue Breakdown by Application (%)
Figure 11. Europe Cancer Testing/Screening Sales (2018-2028)
Figure 12. Sales Breakdown by Type (%)
Figure 13. Sales Breakdown by Type (%)
Figure 14. Sales Breakdown by Application (%)
Figure 15. Revenue Breakdown by Type (%)
Figure 16. Revenue Breakdown by Application (%)
Figure 17. China Cancer Testing/Screening Sales (2018-2028)
Figure 18. Sales Breakdown by Type (%)
Figure 19. Sales Breakdown by Type (%)
Figure 20. Sales Breakdown by Application (%)
Figure 21. Current and Estimated Revenue Breakdown by Type
Figure 22. Revenue Breakdown by Type (%)
Figure 23. Revenue Breakdown by Application (%)
Figure 24. Japan Cancer Testing/Screening Sales (2018-2028)
Figure 25. Sales Breakdown by Type (%)
Figure 26. Sales Breakdown by Type (%)
Figure 27. Sales Breakdown by Application (%)
Figure 28. Revenue Breakdown by Type (%)
Figure 29. Revenue Breakdown by Application (%)
Figure 30. India Cancer Testing/Screening Sales (2018-2028)
Figure 31. Sales Breakdown by Type (%)
Figure 32. Sales Breakdown by Type (%)
Figure 33. Sales Breakdown by Application (%)
Figure 34. Revenue Breakdown by Type (%)
Figure 35. Revenue Breakdown by Application (%)
Figure 36. Korea Cancer Testing/Screening Sales (2018-2028)
Figure 37. Sales Breakdown by Type (%)
Figure 38. Sales Breakdown by Type (%)
Figure 39. Sales Breakdown by Application (%)
Figure 40. Revenue Breakdown by Type (%)
Figure 41. Revenue Breakdown by Application (%)
Figure 42. Southeast Asia Cancer Testing/Screening Sales (2018-2028)
Figure 43. Current and Estimated Sales Breakdown by Type (2018-2028)
Figure 44. Sales Breakdown by Type (%)
Figure 45. Sales Breakdown by Type (%)
Figure 46. Revenue Breakdown by Type (%)
Figure 47. Revenue Breakdown by Application (%)
Figure 48. Industrial Chain
Table 1. Top Manufacturers and Market Segmentation
Table 2. Product Introduction, Application, Picture
Table 3. Cancer Testing/Screening Revenue, by Type (Million USD) (2018-2028)
Table 4. Cancer Testing/Screening Sales, by Type (K Unit) (2018-2028)
Table 5. Cancer Testing/Screening Sales (K Unit) by Application (2018-2028)
Table 6. Cancer Testing/Screening Sales (Million USD) by Application (2018-2028)
Table 7. The Major Downstream Company in China
Table 8. Regional Market Share in Terms of Sales (2022)
Table 9. Regional Market Share in Terms of Revenue (2022&2028)
Table 10. Ranking of Global Top Cancer Testing/Screening Companies by Revenue, Concentration Ratio in 2022
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. US Cancer Testing/Screening Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 13. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 14. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 15. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 16. Current and Estimated Revenue Breakdown by Type
Table 17. Current and Estimated Revenue Breakdown by Application
Table 18. Europe Cancer Testing/Screening Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 19. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 20. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 21. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 22. Current and Estimated Revenue Breakdown by Type
Table 23. Current and Estimated Revenue Breakdown by Application
Table 24. China Cancer Testing/Screening Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 25. Table Current and Estimated Sales Breakdown by Type
Table 26. Current and Estimated Sales Breakdown by Type
Table 27. Current and Estimated Sales Breakdown by Application
Table 28. Current and Estimated Revenue Breakdown by Application
Table 29. Japan Cancer Testing/Screening Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 30. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 31. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 32. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 33. Current and Estimated Revenue Breakdown by Type
Table 34. Current and Estimated Revenue Breakdown by Application
Table 35. India Cancer Testing/Screening Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 36. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 37. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 38. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 39. Current and Estimated Revenue Breakdown by Type
Table 40. Current and Estimated Revenue Breakdown by Application
Table 41. Korea Cancer Testing/Screening Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 42. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 43. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 44. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 45. Current and Estimated Revenue Breakdown by Type
Table 46. Current and Estimated Revenue Breakdown by Application
Table 47. Southeast Asia Cancer Testing/Screening Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 48. Table Current and Estimated Sales Breakdown by Type (2018-2028)
Table 49. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 50. Current and Estimated Revenue Breakdown by Type
Table 51. Current and Estimated Revenue Breakdown by Application
Table 52. Market Price (USD/Unit) for Each Type of Cancer Testing/Screening in US (2018-2022)
Table 53. Market Price (USD/Unit) for Each Type of Cancer Testing/Screening in Europe (2018-2022)
Table 54. Market Price (USD/Unit) for Each Type of Cancer Testing/Screening in China (2018-2022)
Table 55. Market Price (USD/Unit) for Each Type of Cancer Testing/Screening in Japan (2018-2022)
Table 56. Market Price (USD/Unit) for Each Type of Cancer Testing/Screening in India (2018-2022)
Table 57. Market Price (USD/Unit) for Each Type of Cancer Testing/Screening in Korea (2018-2022)
Table 58. Market Price (USD/Unit) for Each Type of Cancer Testing/Screening in Southeast Asia (2018-2022)
Table 59. Key Downstream Customer in Each Application Field
Table 60. Dias Orin Profiles
Table 61. Dias Orin Cancer Testing/Screening Product Introduction
Table 62. Dias Orin Cancer Testing/Screening Sales (Unit), Revenue (Million USD) (2018-2022)
Table 63. Dias Orin Strategic initiatives
Table 64. Epigenetics Profiles
Table 65. Epigenetics Cancer Testing/Screening Product Introduction
Table 66. Epigenetics Cancer Testing/Screening Sales (Unit), Revenue (Million USD) (2018-2022)
Table 67. Epigenetics Strategic initiatives
Table 68. Techlab Profiles
Table 69. Techlab Cancer Testing/Screening Product Introduction
Table 70. Techlab Cancer Testing/Screening Sales (Unit), Revenue (Million USD) (2018-2022)
Table 71. Techlab Strategic initiatives
Table 72. Positive Bioscience Profiles
Table 73. Positive Bioscience Cancer Testing/Screening Product Introduction
Table 74. Positive Bioscience Cancer Testing/Screening Sales (Unit), Revenue (Million USD) (2018-2022)
Table 75. Positive Bioscience Strategic initiatives
Table 76. Genextropy Profiles
Table 77. Genextropy Cancer Testing/Screening Product Introduction
Table 78. Genextropy Cancer Testing/Screening Sales (Unit), Revenue (Million USD) (2018-2022)
Table 79. Genextropy Strategic initiatives
Table 80. M Genomics Profiles
Table 81. M Genomics Cancer Testing/Screening Product Introduction
Table 82. M Genomics Cancer Testing/Screening Sales (Unit), Revenue (Million USD) (2018-2022)
Table 83. M Genomics Strategic initiatives
Table 84. 20/20 GeneSystems Profiles
Table 85. 20/20 GeneSystems Cancer Testing/Screening Product Introduction
Table 86. 20/20 GeneSystems Cancer Testing/Screening Sales (Unit), Revenue (Million USD) (2018-2022)
Table 87. 20/20 GeneSystems Strategic initiatives
Table 88. AB SCIEX Profiles
Table 89. AB SCIEX Cancer Testing/Screening Product Introduction
Table 90. AB SCIEX Cancer Testing/Screening Sales (Unit), Revenue (Million USD) (2018-2022)
Table 91. AB SCIEX Strategic initiatives
Table 92. Abbott Laboratories Profiles
Table 93. Abbott Laboratories Cancer Testing/Screening Product Introduction
Table 94. Abbott Laboratories Cancer Testing/Screening Sales (Unit), Revenue (Million USD) (2018-2022)
Table 95. Abbott Laboratories Strategic initiatives
